摘要
目的:构建结核分支杆菌Ag85B基因在大肠杆菌的融合表达载体,制备MBP/Ag85B融合蛋白并将其纯化。方法:常规方法构建重组表达质粒pMAL-p2-Ag85B,内切酶EcoRⅠ/HindⅢ酶切鉴定;重组表达质粒pMAL-p2-Ag85B转化大肠杆菌,经0.3mmol/L异丙基-β-D-硫代半乳糖苷(isopropyl-β-Dthiogalactoside熏IPTG)诱导表达产生融合蛋白(MBP/Ag85B),Westernblot鉴定表达产物。pMAL纯化树脂(Amyloseresin)对MBP/Ag85B融合蛋白纯化。结果:重组质粒pMAL-p2-Ag85B经EcoRⅠ/HindⅢ酶切后,1%琼脂糖凝胶电泳证实Ag85B正向插入pMAL-p2载体,重组菌经IPTG诱导后,有约70kD蛋白表达,与预期的融合蛋白分子量相符,蛋白表达量约占细菌总蛋白量的40%;Westernblot显示,MBP/Ag85B融合蛋白与人抗结核IgG抗体呈特异性反应;经Amyloseresin纯化后,MBP/Ag85B融合蛋白的纯度可达95%以上。结论:成功构建结核分支杆菌Ag85B重组融合蛋白表达质粒并制备及纯化其融合蛋白,为进一步研究Ag85B生物学功能及其抗原表位分析奠定了物质基础。
Objective: To construct the antigen 85B fusion protein expression vector of mycobacterium tuberculosis (MT) in Escherichia coli(E.coli) and prepare specific antibody to Ag85B. Methods: Ag85B gene was separated from pUC18-Ag85B and then inserted into the downstream of malE of expression vector pMAL-p2. The recombinant expression plasmid pMAL-p2-Ag85B was converted into E,coli,and the MBP/Ag85B fusion protein was expressed by induction of Isopropyl-β-D thiogalactoside (IPTG). The recombinant fusion protein was identified by Western blot test and purified with Amylose resin after sonication. Results: Endonucleases digestion confirmed that Ag85B gene was inserted into the prokaryotic expression vector pMAL-p2. The recombinant exDression Dlasmid pMAL-p2-Ag85B successfully expressed MRP/Ag85B fusion protein in E.coli, and MBP/Ag85B fusion protein showed specific immunological reaction with anti-MT antibody. The purity of the MBP/Ag85B fusion protein was over 95% after purification with Amylose resin. Conclusion: The construction of the prokaryotic expression plamsid of Ag85B and the preparation of MBP/Ag85B fusion protein establish a solid basis for further studying the biological function of Ag85B and preparing the specific antibody against Ag85B.
出处
《山东大学学报(医学版)》
CAS
北大核心
2005年第7期570-573,共4页
Journal of Shandong University:Health Sciences
基金
山东省自然科学基金资助课题(Y98CO5034)。